sur Evotec AG (NASDAQ:EVTCY)
Evotec SE to Release Nine-Month 2024 Financial Results
Evotec SE, a life science company listed on the Frankfurt Stock Exchange and NASDAQ, plans to announce its financial results for the first nine months of 2024 on November 6. The announcement will be accompanied by a conference call, during which the management intends to discuss these results and provide insights into the ongoing priority reset and strategic review process.
The conference call, conducted in English, is scheduled for 2:00 pm CET. Participants can join via a webcast with presentation slides available for both online and phone attendees. An on-demand version of the webcast will be accessible on the company's website.
Evotec, known for its multimodality platform, engages in partnerships to advance therapeutics across various fields including neurology, oncology, and infectious diseases. The company's global operations employ over 5,000 individuals with strategic activities focused in Europe and the USA.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Evotec AG